5 results match your criteria: "At Ochsner Medical Center in New Orleans[Affiliation]"
The COVID war: Building an organizational combat model to reduce chaos.
Nurs Manage
August 2022
At Ochsner Medical Center in New Orleans, La., Leslie Norman is an assistant vice president of nursing, Renee F. DiGiovanni is an assistant vice president of nursing, Deborah A. Ford is a CNO, and Robert V. Flores is an assistant vice president of nursing.
The Implications of Power Mobility on Body Weight in a Veteran Population.
Fed Pract
September 2021
is a Physical Medicine and Rehabilitation Staff Physician, and is a Clinical Psychologist, both at Hunter Holmes McGuire Veterans Affairs Medical Center in Richmond, Virginia. is a Senior Traumatic Brain Injury Specialist for the US Department of Veterans Affairs. is a Physical Medicine and Rehabilitation Staff Physician at Ochsner Medical Center in New Orleans, Louisiana. is a Physical Medicine and Rehabilitation Resident Physician, and David Cifu is Associate Dean of Innovation and Systems Integration, both at Virginia Commonwealth University Health System in Richmond.
Background: The prevalence of obesity is increasing in the United States. A common concern among health care providers is that prescribing a power mobility device (PMD) may decrease physical activity and lead to obesity and increasing morbidity. This study analyzes the effect of PMD prescriptions over a 2-year period on body mass index (BMI) and body weight in a population of veterans both as a whole and in BMI/age subgroups.
View Article and Find Full Text PDFWhat is the role of andexanet alfa in the reversal of anticoagulant effects?
JAAPA
January 2021
Jenna Hill Sewell is a pharmacy resident at the Gulf Coast Veterans Healthcare System in Biloxi, Miss. LaKeisha Williams is a clinical associate professor at Xavier University of Louisiana College of Pharmacy in New Orleans, La. Ellen McKnight is a community pharmacist at Walgreens Pharmacy in Memphis, Tenn. Anthony Nguyen is a clinical pharmacist at Ochsner Medical Center in New Orleans. Miroslav Sarac is an assistant professor at the Faculty of Pharmacy, Novi Sad, University Business Academy in Novi Sad, Serbia. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Although using direct oral anticoagulants increases patient risk for hemorrhagic events, FDA-approved options for reversing anticoagulant effects are limited. This article discusses one of the more recent FDA-approved antidotes, andexanet alfa, and provides guidelines for its safe and effective use.
View Article and Find Full Text PDFNewest lipoglycopeptides for the management of acute bacterial skin and skin structure infections.
Nurse Pract
October 2018
Allison Bell is an associate professor in the Division of Pharmacy Practice and Administrative Sciences at the Univeristy of Cincinnati James L. Winkle College of Pharmacy in Cincinnati, Ohio. S. Travis King is a Clinical Pharmacy Specialist in Infectious Diseases at Ochsner Medical Center in New Orleans, Louisiana. Katie E. Barber is an assistant professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss. Kim G. Adcock is a professor in the Department of Pediatrics at the University of Mississippi Medical Center, Jackson, Miss., and a professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss. Jamie L. Wagner is a clinical assistant professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss. Kayla R. Stover is an associate professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss.
Acute bacterial skin and skin structure infections (ABSSSIs) are some of the most commonly encountered infections worldwide. Hospitalizations as a result of ABSSSIs are associated with high mortality. This article discusses the role of oritavancin and dalbavancin, the two newest lipoglycopeptides, in the context of the other available I.
View Article and Find Full Text PDFThe complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A.
View Article and Find Full Text PDF